Skip to main content
Top
Published in: Journal of Nephrology 5/2018

01-10-2018 | Original Article

Testosterone in renal transplant patients: effect on body composition and clinical parameters

Authors: Danilo Lofaro, Anna Perri, Antonio Aversa, Benedetta Aquino, Martina Bonofiglio, Antonella La Russa, Maria Giovanna Settino, Francesca Leone, Alessandro Ilacqua, Filomena Armentano, Donatella Vizza, Simona Lupinacci, Giuseppina Toteda, Renzo Bonofiglio

Published in: Journal of Nephrology | Issue 5/2018

Login to get access

Abstract

Background

Clinical studies have demonstrated that, after renal transplantation (TX), testosterone deficiency (TD) at the time of the procedure is independently associated with lower survival of the patient and graft. However, data between TD and the functional CAG polymorphism of the androgen receptor promoter (AR) are discordant. We investigated the prevalence of TD and its association with body composition, biochemical parameters, the Aging Males’ Symptoms rating scale (AMS) domains and AR polymorphism.

Methods

In 112 TX patients, we assessed the AMS, biochemical/hormonal (FSH/LH/TT) anthropometric/bioimpedance analysis parameters, and AR CAG polymorphism of AR by gene sequencing.

Results

Median values of total testosterone (TT) were 340 ng/dl and 52% of TX patients were affected by TD. Significant correlations between TT and FSH and FSH and LH (p = 0.005, p < 0.0001, respectively) were found. TD patients had lower estimated glomerular filtration rate (eGFR) and hemoglobin (Hb) (p = 0.034, p = 0.022 respectively) and showed higher values of C-reactive protein (p = 0.023) and fat tissue index/adipose tissue mass (p = 0.034 and p = 0.021, respectively), and lower values of serum albumin (p = 0.003) and high-density lipoprotein-cholesterol (p = 0.038) levels. Significant differences were found in the number of patients on mammalian target of rapamycin inhibitors immunosuppressant therapy (p = 0.045). Logistic regression analysis did not show any correlation between age, AMS scores, TT or CAG repeat length, gonadotropins, time of the transplant, and dialysis.

Conclusions

Our results suggest that in TX recipients an appropriate sexual hormonal evaluation should be performed, as we found a high prevalence of TD. However, further studies are needed to clarify the association between TD and patient and graft survival.
Literature
1.
go back to reference Carrero J, Stenvinkel P (2012) The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 27:4030–4041CrossRefPubMed Carrero J, Stenvinkel P (2012) The vulnerable man: impact of testosterone deficiency on the uraemic phenotype. Nephrol Dial Transplant 27:4030–4041CrossRefPubMed
2.
go back to reference Snyder G, Shoskes DA (2016) Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients. Transl Androl Urol 5:885–889CrossRefPubMedPubMedCentral Snyder G, Shoskes DA (2016) Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients. Transl Androl Urol 5:885–889CrossRefPubMedPubMedCentral
3.
go back to reference Dunkel L, Raivio T, Laine J, Holmberg C (1997) Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure. Kidney Int 51:777–784CrossRefPubMed Dunkel L, Raivio T, Laine J, Holmberg C (1997) Circulating luteinizing hormone receptor inhibitor(s) in boys with chronic renal failure. Kidney Int 51:777–784CrossRefPubMed
4.
go back to reference Schmidt A, Luger A, Horl WH (2002) Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant 17:368–371CrossRefPubMed Schmidt A, Luger A, Horl WH (2002) Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant 17:368–371CrossRefPubMed
5.
go back to reference Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, Saglam M, Stylianou K, Yaman H, Taslipinar A, Vural A, Gok M, Yenicesu M, Daphnis E, Yilmaz (2012) MI. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 7:207–215CrossRefPubMedPubMedCentral Carrero JJ, Kyriazis J, Sonmez A, Tzanakis I, Qureshi AR, Stenvinkel P, Saglam M, Stylianou K, Yaman H, Taslipinar A, Vural A, Gok M, Yenicesu M, Daphnis E, Yilmaz (2012) MI. Prolactin levels, endothelial dysfunction, and the risk of cardiovascular events and mortality in patients with CKD. Clin J Am Soc Nephrol 7:207–215CrossRefPubMedPubMedCentral
6.
go back to reference Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833–876CrossRefPubMed Kaufman JM, Vermeulen A (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833–876CrossRefPubMed
8.
go back to reference Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men. J Clin Endocrinol Metab 91:843–850CrossRefPubMed Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB (2006) Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men. J Clin Endocrinol Metab 91:843–850CrossRefPubMed
9.
go back to reference Palmer BF (2004) Outcomes Associated With Hypogonadism in Men With Chronic Kidney Disease. Advances in Chronic Kidney Disease 11:342–347CrossRefPubMed Palmer BF (2004) Outcomes Associated With Hypogonadism in Men With Chronic Kidney Disease. Advances in Chronic Kidney Disease 11:342–347CrossRefPubMed
10.
go back to reference Iglesias P, Carrero JJ, Díez JJ (2012) Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol 25:31–42CrossRef Iglesias P, Carrero JJ, Díez JJ (2012) Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options. J Nephrol 25:31–42CrossRef
11.
go back to reference Carrero JJ, Qureshi Ar N, Arver S, Parini P, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P (2011) Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant 26:184–190CrossRefPubMed Carrero JJ, Qureshi Ar N, Arver S, Parini P, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P (2011) Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease. Nephrol Dial Transplant 26:184–190CrossRefPubMed
12.
go back to reference Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation into Cancer in Norfolk (EPICNorfolk) Prospective Population Study. Circulation 116:2694–2701CrossRefPubMed Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, Luben R, Welch A, Day N (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European Prospective Investigation into Cancer in Norfolk (EPICNorfolk) Prospective Population Study. Circulation 116:2694–2701CrossRefPubMed
13.
go back to reference Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J (2014) Low Testosterone at Time of Transplant Is Independently Associated with Poor Patient and Graft Survival in Male Renal Transplant Recipients. J Urol 192:1168–1171CrossRefPubMed Shoskes DA, Kerr H, Askar M, Goldfarb DA, Schold J (2014) Low Testosterone at Time of Transplant Is Independently Associated with Poor Patient and Graft Survival in Male Renal Transplant Recipients. J Urol 192:1168–1171CrossRefPubMed
14.
go back to reference Tauchmanova L, Carrano R, Sabbatini S, De Rosa M, Orio F, Palomba S, Cascella T, Lombardi G, Federico S, Colao AM (2004) Hypothalamic–pituitary–gonadal axis function after successful kidney transplantation in men and women. Hum Reprod 19:867–873CrossRefPubMed Tauchmanova L, Carrano R, Sabbatini S, De Rosa M, Orio F, Palomba S, Cascella T, Lombardi G, Federico S, Colao AM (2004) Hypothalamic–pituitary–gonadal axis function after successful kidney transplantation in men and women. Hum Reprod 19:867–873CrossRefPubMed
15.
go back to reference Schmidt A, Luger A, Hörl WH (2002) Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant 17:368–371CrossRefPubMed Schmidt A, Luger A, Hörl WH (2002) Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant 17:368–371CrossRefPubMed
16.
go back to reference Francomano D, Greco EALenzi A, Aversa A (2013) CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? J Sex Med 10:2373–2381CrossRefPubMed Francomano D, Greco EALenzi A, Aversa A (2013) CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism? J Sex Med 10:2373–2381CrossRefPubMed
18.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
19.
go back to reference Aversa A, Morgentaler A (2015) The practical management of testosterone deficiency in men. Nat Rev Urol 12:641–650CrossRefPubMed Aversa A, Morgentaler A (2015) The practical management of testosterone deficiency in men. Nat Rev Urol 12:641–650CrossRefPubMed
20.
go back to reference Dang J, Peng L, Zhong HJ, Huo ZH (2015) Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population. Genet Mol Res 14:10258–10266CrossRefPubMed Dang J, Peng L, Zhong HJ, Huo ZH (2015) Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population. Genet Mol Res 14:10258–10266CrossRefPubMed
21.
go back to reference Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA (2014) Serum testosterone levels and mortality in men with CKD stages 3–4. Am J Kidney Dis 64:367–374CrossRefPubMedPubMedCentral Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA (2014) Serum testosterone levels and mortality in men with CKD stages 3–4. Am J Kidney Dis 64:367–374CrossRefPubMedPubMedCentral
22.
go back to reference Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3:835–845CrossRefPubMed Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, Kliem V, Legendre C, Morais Sarmento AL, Vincenti F (2003) Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3:835–845CrossRefPubMed
23.
go back to reference Gafter-Gvili A, Ayalon-Dangur I, Cooper L, Shochat T, Rahamimov R, Gafter U, Mor E, Grossman A (2017) Post-transplantation anemia in kidney transplant recipients: A retrospective cohort study. Medicine (Baltimore) 96:e7735CrossRef Gafter-Gvili A, Ayalon-Dangur I, Cooper L, Shochat T, Rahamimov R, Gafter U, Mor E, Grossman A (2017) Post-transplantation anemia in kidney transplant recipients: A retrospective cohort study. Medicine (Baltimore) 96:e7735CrossRef
24.
go back to reference Majzoub A, Shoskes DA (2016) A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients. Translational Andrology Urology 5:814–818CrossRefPubMed Majzoub A, Shoskes DA (2016) A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients. Translational Andrology Urology 5:814–818CrossRefPubMed
25.
go back to reference Georgiou K, Dounousi E, Harissis HV (2016) Calcineurin inhibitors and male fertility after renal transplantation: a review. Andrologia 48:483–490CrossRefPubMed Georgiou K, Dounousi E, Harissis HV (2016) Calcineurin inhibitors and male fertility after renal transplantation: a review. Andrologia 48:483–490CrossRefPubMed
26.
go back to reference Cavanaugh TM, Schoenemen H, Goebel J (2012) The impact of sirolimus on sex hormones in male adolescent kidney recipients. Pediatr Transplant 16:280–285CrossRefPubMed Cavanaugh TM, Schoenemen H, Goebel J (2012) The impact of sirolimus on sex hormones in male adolescent kidney recipients. Pediatr Transplant 16:280–285CrossRefPubMed
27.
go back to reference Krämer BK, Neumayer HH, Stahl R, Pietrzyk M, Krüger B, Pfalzer B, Bourbigot B, Campbell S, Whelchel J, Eris J, Vitko S, Budde K, RADA2307 Study Group (2005) Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab. Transplant Proc 37:1601–1604CrossRefPubMed Krämer BK, Neumayer HH, Stahl R, Pietrzyk M, Krüger B, Pfalzer B, Bourbigot B, Campbell S, Whelchel J, Eris J, Vitko S, Budde K, RADA2307 Study Group (2005) Graft function, cardiovascular risk factors, and sex hormones in renal transplant recipients on an immunosuppressive regimen of everolimus, reduced dose of cyclosporine, and basiliximab. Transplant Proc 37:1601–1604CrossRefPubMed
28.
go back to reference Boobes Y, Bernieh B, Saadi H, Raafat Al Hakim M, Abouchacra S (2010) Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus. Int Urol Nephrol 42:493–498CrossRefPubMed Boobes Y, Bernieh B, Saadi H, Raafat Al Hakim M, Abouchacra S (2010) Gonadal dysfunction and infertility in kidney transplant patients receiving sirolimus. Int Urol Nephrol 42:493–498CrossRefPubMed
29.
go back to reference Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I (2017) Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis. Arthritis Rheumatol 69:1272–1279CrossRefPubMed Arnaud L, Nordin A, Lundholm H, Svenungsson E, Hellbacher E, Wikner J, Zickert A, Gunnarsson I (2017) Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis. Arthritis Rheumatol 69:1272–1279CrossRefPubMed
30.
go back to reference Fugl-Meyer KS, Nilsson M, Hylander B, Lehtihet M (2017) Sexual Function and Testosterone Level in Men With Conservatively Treated Chronic Kidney Disease. American Journal of Men’s Health 11:1069–1076CrossRefPubMedPubMedCentral Fugl-Meyer KS, Nilsson M, Hylander B, Lehtihet M (2017) Sexual Function and Testosterone Level in Men With Conservatively Treated Chronic Kidney Disease. American Journal of Men’s Health 11:1069–1076CrossRefPubMedPubMedCentral
31.
go back to reference Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF (2010) Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies. Am J Kidney Dis 56:670–685CrossRefPubMed Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F, Lucisano G, Craig JC, Ruospo M, Gentile G, Manfreda VM, Querques M, Stroumza P, Torok M, Celia E, Gelfman R, Ferrari JN, Bednarek-Skublewska A, Dulawa J, Bonifati C, Hegbrant J, Wollheim C, Jannini EA, Strippoli GF (2010) Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies. Am J Kidney Dis 56:670–685CrossRefPubMed
32.
go back to reference Tavallaii SA, Mirzamani M, Heshmatzade Behzadi A, Assari S, Khoddami Vishteh HR, Hajarizadeh B, Einollahi B (2009) Sexual Function: A Comparison Between Male Renal Transplant Recipients and Hemodialysis Patients. J Sex Med 6:142–148CrossRefPubMed Tavallaii SA, Mirzamani M, Heshmatzade Behzadi A, Assari S, Khoddami Vishteh HR, Hajarizadeh B, Einollahi B (2009) Sexual Function: A Comparison Between Male Renal Transplant Recipients and Hemodialysis Patients. J Sex Med 6:142–148CrossRefPubMed
33.
go back to reference Park MG, Koo HS, Lee B (2013) Characteristics of testosterone deficiency syndrome in men with chronic kidney disease and male renal transplant recipients: a cross-sectional study. Transplant Proc 45:2970–2974CrossRefPubMed Park MG, Koo HS, Lee B (2013) Characteristics of testosterone deficiency syndrome in men with chronic kidney disease and male renal transplant recipients: a cross-sectional study. Transplant Proc 45:2970–2974CrossRefPubMed
34.
go back to reference Tirabassi G, Cignarelli A, Perrini S, Delli Muti N, Furlani G, Gallo M, Pallotti F, Paoli D, Giorgino F, Lombardo F, Gandini L, Lenzi A, Balercia G (2015) Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action. Int J Endocrinol2015:298107 Tirabassi G, Cignarelli A, Perrini S, Delli Muti N, Furlani G, Gallo M, Pallotti F, Paoli D, Giorgino F, Lombardo F, Gandini L, Lenzi A, Balercia G (2015) Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action. Int J Endocrinol2015:298107
35.
go back to reference Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M (2016) Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest 39:967–981CrossRefPubMed Corona G, Giagulli VA, Maseroli E, Vignozzi L, Aversa A, Zitzmann M, Saad F, Mannucci E, Maggi M (2016) Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest 39:967–981CrossRefPubMed
36.
go back to reference Pantik C, Cho YE, Hathaway D, Tolley E, Cashion A (2017) Characterization of Body Composition and Fat Mass Distribution 1 Year After Kidney. Transplantation Prog Transplant 27:10–15CrossRefPubMed Pantik C, Cho YE, Hathaway D, Tolley E, Cashion A (2017) Characterization of Body Composition and Fat Mass Distribution 1 Year After Kidney. Transplantation Prog Transplant 27:10–15CrossRefPubMed
38.
go back to reference Guida B, Trio R, Laccetti R, Nastasi A, Salvi E, Perrino NR, Caputo C, Rotaia E, Federico S, Sabbatini M (2007) Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. Nephrol Dial Transplant 22:3304–3310CrossRefPubMed Guida B, Trio R, Laccetti R, Nastasi A, Salvi E, Perrino NR, Caputo C, Rotaia E, Federico S, Sabbatini M (2007) Role of dietary intervention on metabolic abnormalities and nutritional status after renal transplantation. Nephrol Dial Transplant 22:3304–3310CrossRefPubMed
39.
go back to reference Nagy K, Ujszaszi A, Remport A, Kovesdy CP, Mucsi I, Molnar MZ, Mathe Z (2016) Association of Abdominal Circumference, Body Mass Index, and Inflammation in Kidney Transplant Recipients. J Ren Nutr 26:325–333CrossRefPubMed Nagy K, Ujszaszi A, Remport A, Kovesdy CP, Mucsi I, Molnar MZ, Mathe Z (2016) Association of Abdominal Circumference, Body Mass Index, and Inflammation in Kidney Transplant Recipients. J Ren Nutr 26:325–333CrossRefPubMed
40.
go back to reference Eckersten D, Giwercman A, Christensson A (2015) Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Asian J Androl 17:149–153CrossRefPubMed Eckersten D, Giwercman A, Christensson A (2015) Male patients with terminal renal failure exhibit low serum levels of antimüllerian hormone. Asian J Androl 17:149–153CrossRefPubMed
41.
go back to reference Aniort J, Kaysi S, Garrouste C (2018) CKD complications in kidney-transplanted patients going back to dialysis: impact on patients outcomes. J Neph 31:147–155CrossRef Aniort J, Kaysi S, Garrouste C (2018) CKD complications in kidney-transplanted patients going back to dialysis: impact on patients outcomes. J Neph 31:147–155CrossRef
Metadata
Title
Testosterone in renal transplant patients: effect on body composition and clinical parameters
Authors
Danilo Lofaro
Anna Perri
Antonio Aversa
Benedetta Aquino
Martina Bonofiglio
Antonella La Russa
Maria Giovanna Settino
Francesca Leone
Alessandro Ilacqua
Filomena Armentano
Donatella Vizza
Simona Lupinacci
Giuseppina Toteda
Renzo Bonofiglio
Publication date
01-10-2018
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 5/2018
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-018-0513-3

Other articles of this Issue 5/2018

Journal of Nephrology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine